Clinical updates, including trial initiations, enrollment status and data readouts and publications: Silk Road Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amgen, Arbutus, Assembly, Astrazeneca, Innovation, Partner, Pharvaris, Revive, XNK.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiofocus, Cell Science Systems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adial, Aimmune, Aivita, Altimmune, Bioage, Biontech, Bioxcel, Bluebird, BMS, Celsion, Chimerix, Clene, CNS, Compugen, EMD Serono, Entera, I-Mab, GSK, Karuna, Kronos, Pfizer, Regeneron, Roche, Springworks, Stero, Viela.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Appliedvr, Irhythm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Click, Constant, Gtreebnt, Locus, Longeveron, Marinomed, Nanoform, Neurorx, Novavax, Opthea, Otsuka, Regentree, Salarius, Takeda, Theralase, Theravance.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Adagio, Algernon, Astellas, Bionomics, Biontech, Biophytis, Clene, Diffusion, Evgen, Gannex, Glaxosmithkline, Immunic, India Globalization Capital, Kintor, Kyowa Kirin, Mesoblast, Neuren, Novavax, Pfizer, PTC, Realta Life Sciences, Recce, Redhill, Sagent, Sanofi, Vtv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abfero, Ampio, Arrys, Chiesi, Eiger, Frequency, LG, Matrisys, Octapharma, Protalix, Redhill, Revance, Stealth, Targovax, TG, Union, Valbiotis, Vtv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Bionomics, Can-Fite, Cartesian, Gannex, GSK, Immunicum, Ipsen, Italfarmaco, Kintor, Mediwound, Novavax, Otonomy, Sanofi, Valneva, VBL.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mirimus.